Innate Pharma (ADR)
Develops innate-immunity-based antibody therapies for cancer alongside AstraZeneca and Sanofi collaborations.
$2.22
After-hours close0.00 (0.00%)
At close$2.22(−0.45%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 0.20%Insiders —
Shares outstanding 93.90M · Float 70.57M · 75.2% free float
Institutions13F, as of Mar 31, 2026
9 holders · 184.0K shares · 1 new position · 1 increased · 6 reduced · 3 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Lion Point Capital, LP | 81.2K | 0.09% | 0 | May 15, 2026 |
| Morgan Stanley | 43.5K | 0.05% | −2.9K | May 15, 2026 |
| Jane Street Group, LLC | 43.4K | 0.05% | −49.4K | May 12, 2026 |
| Millennium Management LLC | 10.1K | 0.01% | −10.2K | May 15, 2026 |
| Rhumbline Advisers | 4.7K | 0.01% | −470 | May 12, 2026 |
| UBS Group AG | 861 | 0.00% | −86 | May 5, 2026 |
| Gamma Investing LLC | 240 | 0.00% | −833 | Apr 6, 2026 |
| Farther Finance Advisors, LLC | 10 | 0.00% | 0 | Apr 7, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Sanofi | 9.05% | 8.35M | 13G | Apr 29, 2025 ↗ |
| MedImmune Limitedincl. AstraZeneca PLC | 8.30% | 7.83M | 13D | Feb 6, 2026 ↗ |
| Caisse des depots et consignationsincl. EPIC Bpifrance, CDC Croissance S.A. +2 more | 7.90% | 7.32M | 13D | May 7, 2025 ↗ |
InsidersForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.